[Disseminated histoplasmosis and AIDS. Report of 4 cases].

Beatriz Bayés(Hospital Universitari Germans Trias i Pujol), B Clotet, Joan Romeu(Hospital Universitari Germans Trias i Pujol), M Vaquero, G. Sirera(Hospital Universitari Germans Trias i Pujol), A. Rosell, Miquel Ribera, José‐Tomás Navarro(Universitat Autònoma de Barcelona)

PubMed

May 11, 1996

Cited by 19

Related Papers

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients

|Blood|2013|189

Human immunodeficiency virus‐associated plasmablastic lymphoma

|Cancer|2012|178

Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma

|Haematologica|2007|123

Influence of highly active anti‐retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome‐related non‐Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone

|British Journal of Haematology|2001|104

Bortezomib plus <scp>EPOCH</scp> is effective as frontline treatment in patients with plasmablastic lymphoma

|British Journal of Haematology|2018|90